Drug profile · INN
ethambutol hydrochloride
ETHAMBUTOL HYDROCHLORIDE
ethambutol hydrochloride (ETHAMBUTOL HYDROCHLORIDE) is a arabinosyltransferase a inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — ethambutol hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ethambutol hydrochloride (ETHAMBUTOL HYDROCHLORIDE) is a arabinosyltransferase a inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Arabinosyltransferase A inhibitor
Primary target: Probable arabinosyltransferase A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is ethambutol hydrochloride?
ethambutol hydrochloride (ETHAMBUTOL HYDROCHLORIDE) is a arabinosyltransferase a inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ethambutol hydrochloride?
ETHAMBUTOL HYDROCHLORIDE is a marketed brand name for ethambutol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ethambutol hydrochloride?
ethambutol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.